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Multicellular aggregation of maltol-modified cells
triggered by Fe3+ ions†
Alexander Ciupa, Paul A. De Bank and Lorenzo Caggiano*
The synthesis of a maltol-derived hydrazide is describedwhich, once
attached to a cell surface, induces rapid multicellular aggregation
selectively in the presence of Fe3+ ions. Heterocellular aggregates
are also reported.
Tissues and organs are made of multiple cell types arranged in
three-dimensional (3D) structures. The development of model 3D
multicellular structures in vitro is of great interest as it has potential
applications in tissue engineering1 and as tumour models for drug
testing.2 A number of techniques have been used to generate 3D
cell aggregates3–8 and we now report that ionic cross-linking, which
has been extensively used to form hydrogels (e.g. alginate)9 and
induce self-assembly of collagen peptides,10,11 can selectively
generate multicellular aggregates in the presence of specific ions
using cells decorated with a maltol derivative.
Maltol (3-hydroxy-2-methyl-4-pyrone, 1, Scheme 1) is a commonly
used flavour enhancer found in many foodstuﬀs such as beer and
bread, aﬀording a sweet caramel-like odour.12 It is a bidentate
ligand and derivatives of maltol have found medicinal and clinical
applications,13 such as deferiprone 1a used therapeutically as an
iron chelator.14–19 Macromolecular iron chelators have also been
reported20 and somemaltol derivatives exhibit antimalarial activity21
and antiproliferative activity against tumour cells.22,23 We wished to
attach maltol derivatives to cells and investigate inducing cellular
aggregation through metal chelation as outlined in Scheme 1.
Owing to maltol’s affinity for Fe3+ ions, aggregation should
selectively occur in their presence and not with other ions found
in the cell culture medium.
Cells have been previously modified by chemoselective ligation
with hydrazides.4–6,24 Therefore, we explored the synthesis and use of
maltol hydrazide 6 to trigger multicellular aggregation in the
presence of Fe3+ ions. Following previous reports,14,15 maltol 1 was
initially protected as the benzyl ether 2 (87%), which upon treatment
with b-alanine gave the corresponding acid 3 in 70% yield
(Scheme 2). Transformation to the N-hydroxysuccinimide ester14,15
and reaction with NH2NH2 was examined, although we experienced
difficulties in purifying the product. Instead, conversion to the
methyl ester 4 (98% yield) and simple nucleophilic substitution with
NH2NH2 gave the hydrazide product 5 which could be readily
purified by silica gel column chromatography in 62% yield. Depro-
tection of the benzyl ether was achieved using H2 and Pd/C and gave
the desired maltol-derived hydrazide 6 in 84% yield. Only one
Scheme 1 Schematic representation of chelate-mediated cell aggregation.
Scheme 2 Synthesis of maltol-derived hydrazide 6. (i) BnCl, NaOH, MeOH/H2O.
(ii) b-Alanine, NaOH, EtOH/H2O. (iii) AcCl, MeOH. (iv) NH2NH2, MeOH. (v) H2,
Pd/C, MeOH.
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purification by column chromatography was required overall and the
five-step synthesis can be readily performed on gram-scale.
With the maltol-derived hydrazide 6 in hand, we were able to
investigate its attachment to cells. Human colon carcinoma (HT29)
and highly metastatic human breast carcinoma (MDA-MB-231) cell
lines were chosen as model cells as they are well characterised and
have predictable growth properties. Since maltol derivatives exhibit
antiproliferative activities with tumour cells,22,23 the hydrazide 6 was
initially examined for activity in these cell lines using the MTS
assay.25 The results showed weak antiproliferative activity after
72 h in the cell lines examined, (IC50 > 200 mM in HT29 and
MDA-MB-231, ESI†) suggesting that further cell-based studies
should be conducted at a concentration of 200 mM or below.
The HT29 cell surface was modified following previous reports
using mild oxidation conditions (1 mM NaIO4, 10 min, 4 1C) to
generatenon-native aldehydes fromthe sialic acid residueson the cell
surface.4–6,24,26 The cells were then exposed to maltol hydrazide 6
(100mM,60min, 20 1C) to generate the correspondinghydrazone and
thereby attaching themaltol derivative to the cell surface (see ESI† for
experimental procedure). Theunmodifiedandmaltol-modifiedHT29
cells were resuspended in serum free medium in agarose-coated six-
well plates and then treated with FeCl3 in phosphate buffered saline
(PBS, 50 mM, 20 1C) with gentle agitation by rocking (Fig. 1 and ESI†).
After 10 min, multicellular aggregation of the maltol-modified cells
was observed only in the presence of Fe3+, with no significant
aggregates seen in the absence of Fe3+ or with the unmodified cells.
After 20 min of agitation, large multicellular aggregates had
formed with the maltol-modified cells in the presence of Fe3+ which
were visible to the naked eye. These results were obtained in serum-
free culture medium and similar findings were also observed in PBS
(not shown). However, performing the experiments in complete
culture medium, containing 10% foetal bovine serum, resulted in
no cellular aggregation. Presumably iron-chelating proteins such as
transferrin present in the serum sequester the Fe3+ ions, preventing
metal-mediated aggregation. Therefore, all further experiments were
performed in serum-free culture medium.
Various Fe3+ concentrations and incubation times were
examined with both unmodified and maltol-modified HT29 cells
in order to optimise the aggregation process (Fig. 2). The apparent
aggregate area was calculated from nine randomly selected images
from three independent experiments, using previous methods.5 In
the presence of 0, 5 and 20 mM FeCl3 only small aggregates were
observed after 20 min, although increasing the concentration to
50 mM resulted in larger aggregate sizes in only the maltol-modified
HT29 cells (Fig. 2i). Increasing Fe3+ concentration to 200 mM resulted
in smaller aggregate sizes, possibly due to Fe3+ saturation of the
maltol-derivatives. Due to toxicity associated with excess Fe3+,27,28
50 mM was chosen as the optimal concentration. Time was also
investigated and showed that longer times gave larger aggregates, as
one would expect (Fig. 2ii). However, prolonged exposure (up to
180 min) also led to some aggregation of the unmodified cells, but
only in the presence of Fe3+. These aggregates were much smaller
and slower to form than observed with the maltol-modified cells
(see ESI†) and may be due to weak Fe-chelation by the native sugars
present on the cell surface.
Although selective for Fe3+, maltol derivatives can also chelate
other metal ions such as Ru3+,29 Cu2+ and Zn2+.13 To investigate the
selectivity of metal-mediated aggregation of maltol-modified cells,
the metal chlorides (MClx) of these ions were examined under the
optimised aggregation conditions (ESI†). The results demonstrate
that only in the presence of 50 mM of Fe3+ were multicellular
Fig. 1 Representative images of maltol-modified HT29 cells in the presence of 50 mM FeCl3. Scale bars = 400 mm and the results are typical of three independent
experiments (provided in the ESI† together with images of unmodified cells in presence and absence of FeCl3).
Fig. 2 The eﬀects of (i) Fe3+ concentration after 20 min agitation, and (ii)
agitation time with 50 mM Fe3+ on mean apparent aggregate area for unmodi-
fied and maltol-modified HT29 cells. Data shown as mean  standard error of
three independent experiments.
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aggregates observed after 20 min, with no aggregation apparent in
the presence of Ru3+, Cu2+ or Zn2+ under the same conditions. The
addition of potent Fe-chelators, such as EDTA or maltol 1 itself, to
established aggregates did not reverse the process and aggregates
appeared to be unaﬀected.
To examine the eﬀects of maltol modification and exposure to
Fe3+ on cell proliferation, modifiedMTS assays were performed and
readings taken at 24, 48 and 72 h (Fig. 3). After 24 h, the optical
density (OD) reading for the unmodified cells and maltol-modified
cells were all comparable, both in the absence and presence of
50 mM Fe3+. This data suggests that cells modified with the maltol-
derived hydrazide are viable and, in addition, that the presence of
50 mM Fe3+ in both cell types did not have a detrimental eﬀect.
Similar results were also observed after 48 and 72 h.
The eﬀects of cell aggregation using two diﬀerent cell types was
also examined, using human colon carcinoma (HT29) and human
breast carcinoma (MDA-MB-231) cell lines functionalised with the
maltol-derived hydrazide 6. To visually diﬀerentiate the cell types,
HT29 and MDA-MB-231 cells were fluorescently labelled green and
red respectively using CellTrackert. The addition of 50 mM Fe3+ to
the labelled maltol-modified cells led to the formation of hetero-
cellular aggregates shown in Fig. 4. The HT29 (green) and MDA-MB-
231 (red) cells appear randomly arranged within the aggregate giving
areas of yellow, resulting from the overlap of red and green cells.
This result is of particular note as it demonstrates that modifying
the cell surface with the maltol-derivative 6 and aggregation in the
presence of Fe3+ can be applied to diﬀerent cell types. Further studies
will investigate possible self-organisation of heterocellular aggregates
as reported by Kojima.8
In summary, these results describe the eﬃcient synthesis of
the novel maltol-derived hydrazide 6 and its attachment to two
diﬀerent cancer cell lines. Preliminary experiments show that
multicellular aggregation can be selectively achieved with Fe3+
ions, even in the presence of other ions, generating 3D aggre-
gates on demand which could find various applications.
Although cancer cells were used in this study, this approach
could be applied to any cell type possessing sialic acid residues
on the surface. It could be used with cells which do not naturally
aggregate or to template layers of diﬀerent cells to create
predictable multicellular structures for use in tissue engineering.
We are grateful to the University of Bath for providing a
studentship for AC and also wish to acknowledge RCUK and the
University of Bath for the fellowship to LC.
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